Economic Evaluation of Recombinant Factor VIII FC Fusion Protein (RFVIIIFC) for Immune Tolerance Induction (ITI) in Patients with Hemophilia a WHO Develop Inhibitors Under the Brazilian Unified Health System (SUS) Perspective
Abstract
Authors
V Teich N Li K Brito S Krishnan J Su